New biomarker could help monitor treatments for rare nerve disease
NCT ID NCT06496451
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 25 times
Summary
This study aimed to find a way to measure frataxin mRNA in blood and spinal fluid from people with Friedreich's ataxia. The researchers used tiny particles called exosomes to detect the mRNA. Ten adults with the disease provided samples during one visit. If successful, this method could help doctors monitor whether treatments are working to increase frataxin levels in the brain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FRIEDREICH ATAXIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.